Skip to main content
John Beigel, MD, Internal Medicine, North Bethesda, MD, Ascension Saint Agnes Hospital

JohnHerberBeigelMD

Internal Medicine North Bethesda, MD

Critical Care Medicine, Infectious Disease

Physician

Dr. Beigel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Beigel's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Critical Care Medicine (Internal Medicine), 2000 - 2004
  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2001 - 2003
  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1995 - 1998
  • The University of Toledo College of Medicine
    The University of Toledo College of MedicineClass of 1995

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2003 - 2024
  • DC State Medical License
    DC State Medical License 2003 - 2013
  • OH State Medical License
    OH State Medical License 1996 - 2007
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Safety, Tolerability, and Pharmacokinetics of Radavirsen (AVI‐7100), an Antisense Oligonucleotide Targeting Influenza a M1/M2 Translation  
    Richard T Davey, John H Beigel, British Journal of Clinical Pharmacology

Press Mentions

  • COVID-19 Vaccines: From Nasal Drops to a Redesign, What 2023 Could Have in Store
    COVID-19 Vaccines: From Nasal Drops to a Redesign, What 2023 Could Have in StoreJanuary 9th, 2023
  • Monkeypox Appears to Recede, but Risks and Uncertainties Linger
    Monkeypox Appears to Recede, but Risks and Uncertainties LingerSeptember 26th, 2022
  • FDA to Stretch Monkeypox Vaccine Supply via Intradermal Injection
    FDA to Stretch Monkeypox Vaccine Supply via Intradermal InjectionAugust 12th, 2022
  • Join now to see all

Hospital Affiliations